|By Marketwired .||
|July 8, 2014 01:30 PM EDT||
TORONTO, ON -- (Marketwired) -- 07/08/14 -- Easton Pharmaceuticals Inc. (OTC: EAPH) - announces that it has advanced funds and closed on an agreement to invest and purchase an ownership interest in AMFIL Technologies Inc. and The mPact -GROzone Antimicrobial Systems Line of Products.
The agreement includes an option to purchase warrants allowing Easton to purchase an additional ownership interest up to 32.5% of AMFIL. The mPact -GROzone Antimicrobial Systems is an exclusive application geared towards the Medical Marijuana Industry and other related legal marijuana growing/processing facilities. The mPact -GROzone Antimicrobial Systems is derived from the existing mPact technology which is mainly focused towards the food and beverage industries with successfully installed and performing units cross - sectionally in the Food/Beverage and Fresh Produce Industries, e.g. Sysco Foods, Nestles, Sun Pacific, Thornbury Apple Cidery, Golden Town Apple, etc. A growing niche market has now been created with the burgeoning Medical Marijuana industry in both the United States and Canada as well as other parts of the world.
Easton Pharmaceuticals has advanced funds and acquired an initial minority ownership interest in AMFIL and its mPact -GROzone Antimicrobial System which has been designed and is currently in the process of being integrated into a commercially licensed, state of the art medical marijuana grow facility in Colorado. This facility is one of Colorado's premier Medical Marijuana organizations with an 18,000 sq. ft. indoor hydroponic growing area as well as a 26,000 sq. ft. greenhouse facility that is currently under expansion to 56,000 sq. ft. with a completion date in July 2014. Development is also under way for one of the largest indoor cultivation facilities in Colorado, boasting more than 200,000 square feet of hydroponic growing area. This company also has four retail outlets. A GROzone 60 Antimicrobial System is currently being assembled for installation in this state-of-the-art facility to help meet and exceed the expectations and regulations imposed on growers and the end product that is being distributed to their patients.
As the medical marijuana industry expands, the rules and regulations will naturally become more stringent and overwhelming to growers.
"Producers of marijuana for medical purposes are subject to compliance and enforcement measures similar to those in place for other producers of controlled substances. They must meet strict security, control and reporting requirements, and they are regularly inspected," said Health Canada. (http://www.huffingtonpost.ca/2014/04/22/medical-marijuana-recall_n_5189032.html)
"For the second time in less than a month, Health Canada is issuing a recall of medical marijuana. Clearview, Ont.-based Peace Naturals Project issued a voluntary recall for a batch of its prescription pot (k-farms lot:K1-KFM-001-14) after it tested positive for bacteria outside the acceptable limits, Health Canada said." (http://www.torontosun.com/2014/05/11/health-canada-recalls-medical-marijuana-for-2nd-time-in-a-month)
In April, "Cannabis inspectors visited the Greenleaf production site and "identified issues with processes that affect quality control, good production practices and oversight -- this includes residues from use of unregistered pesticides, unsanitary production conditions, concerns with testing standards and/or control of plant materials." (http://news.nationalpost.com/2014/04/23/purple-kush-recall-another-road-bump-after-new-medical-marijuana-rules-rolled-out/)
The mPact -GROzone Antimicrobial Systems product line will satisfy all the antimicrobial needs of a grow environment to be a fully sanitized and legally producing medical marijuana facility.
The mPact -GROzone Antimicrobial Systems product line eliminates the problems encountered in medicinal marijuana and all types of grow facilities in general by providing a sanitization unit that is a combination of two ozone technologies. It is a multi-functional system which eliminates 99.9% of airborne pathogens, mold and pests such as aphids, whiteflies and spider mites that develop in medical marijuana grow facilities. It is also allows for constant and regulated PPM's of ozone to filter and purify the reservoir and liquid solutions used in growing mediums to prevent algae, bacterial culture and mold growth. The system, in general will also provide multi-surface cleaning to equipment, walls and floors, airborne pathogens and pests; as well as producing biologically stable water that does not promote excessive bacterial growth and regrowth in the distribution system feeding the growing medium. This oxygen based 'green' technology is an excellent environmentally friendly alternative and replacement to the harmful and carcinogenic chemicals currently being used in the industry and by oxygenating the water and delivering the regulated PPM doses in the water supply, the overall health, well-being and yield of the plant should be noticeable compared to similar plants not utilizing the system. It is expected that as an added by-product of installing the mPact -GROzone Antimicrobial Systems, room temperature will also be kept slightly cooler alleviating stress off the fans, hepa filters and ventilation systems, increased odor control, there will be reduced CO2 usage and water consumption will be lowered.
Roger Mortimer, President of "Amfil Technologies Inc. commented, "We are very excited about the future of the GROzone product line as well as the benefits and peace of mind the product will bring to legally producing grow facilities worldwide. As the industry gets more and more regulated, we expect medicinal marijuana and medicinal marijuana related products to continue moving towards food, beverage and drug industry standards." Mr. Mortimer further stated, "As more facilities experience recalled harvests and as the GROzone line of products becomes more and more known and accepted within the industry, facilities and customers of the facilities utilizing the GROzone units should be assured that the product they are receiving is of the highest calibre and should pass the most rigorous testing procedures. To date the interest in the product has been positive and the company will do everything in its power to meet and exceed all orders and expectations of the product."
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors that owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues related towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company is also endeavoring to enter other potentially lucrative industries such as medical marijuana. The company's gel formulation is thought to be an innovative and unique transdermal delivery system. Easton Pharmaceuticals' product "VIORRA" is an over-the-counter, topical daily use product and aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder); the world market for these female conditions is conservatively estimated to be in the billions.
For More Information Visit:
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any proposals, initiatives or negotiations will result in what the company had originally intended. Any investment made into Easton Pharmaceuticals would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: [email protected]
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an In...
Oct. 25, 2014 05:00 PM EDT Reads: 1,704
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy architecture and infrastructure into account. Then the reality is that most enterprises are embarking on a hybrid cloud...
Oct. 25, 2014 11:45 AM EDT Reads: 1,821
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, will focus on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle development and testing environments. Anne Plese is a marketing and technology enthusiast/realist with over 19...
Oct. 25, 2014 10:00 AM EDT Reads: 1,687
StackIQ offers a comprehensive software suite that automates the deployment, provisioning, and management of Big Infrastructure. With StackIQ’s software, you can spin up fully configured big data clusters, quickly and consistently — from bare-metal up to the applications layer — and manage them efficiently. Our software’s modular architecture allows customers to integrate nearly any application wi...
Oct. 25, 2014 10:00 AM EDT Reads: 1,767
As Platform as a Service (PaaS) matures as a category, developers should have the ability to use the programming language of their choice to build applications and have access to a wide array of services. Bluemix is IBM's open cloud development platform that enables users to easily build cloud-based, creative mobile and web applications without having to spend large amounts of time and resources o...
Oct. 25, 2014 08:00 AM EDT Reads: 1,759
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at Internet of @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, will discuss how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will nee...
Oct. 24, 2014 09:30 PM EDT Reads: 1,398
When you set off to build an app that will change the world, designing your system architecture to be reliable and scalable is important but the stark reality is that, for your MVP, you probably had a “need for speed” (of development). You didn’t know what all the axes were to scale your application, where your stress points would be, and what weird and wonderful ways your customers would use it d...
Oct. 24, 2014 09:00 PM EDT Reads: 1,200
Compute virtualization has been transformational, yet security policy implementation and enforcement has lagged behind in agility and automation. There are a number of key considerations when implementing policy in private and hybrid clouds. In his session at 15th Cloud Expo, Holland Barry, VP of Technology at Catbird, will discuss the impact of this new paradigm and what organizations can do to...
Oct. 24, 2014 07:00 PM EDT Reads: 1,521
Samsung VP Jacopo Lenzi, who headed the company's recent SmartThings acquisition under the auspices of Samsung's Open Innovaction Center (OIC), answered a few questions we had about the deal. This interview was in conjunction with our interview with SmartThings CEO Alex Hawkinson. IoT Journal: SmartThings was developed in an open, standards-agnostic platform, and will now be part of Samsung's Ope...
Oct. 23, 2014 11:45 PM EDT Reads: 2,681
SYS-CON Events announced today that Red Hat, the world's leading provider of open source solutions, will exhibit at Internet of @ThingsExpo, which will take place on November 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA. Red Hat is the world's leading provider of open source software solutions, using a community-powered approach to reliable and high-performing cloud, Linux, ...
Oct. 23, 2014 11:30 PM EDT Reads: 1,726